These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Formation of modified cytosine residues in the presence of depurinated DNA. Rentel C; Wang X; Batt M; Kurata C; Oliver J; Gaus H; Krotz AH; McArdle JV; Capaldi DC J Org Chem; 2005 Sep; 70(20):7841-5. PubMed ID: 16277303 [TBL] [Abstract][Full Text] [Related]
51. Separation and characterization of diastereoisomers of antisense oligodeoxyribonucleoside phosphorothioates. Murakami A; Tamura Y; Wada H; Makino K Anal Biochem; 1994 Dec; 223(2):285-90. PubMed ID: 7887475 [TBL] [Abstract][Full Text] [Related]
52. In vivo stability and disposition of a self-stabilized oligodeoxynucleotide phosphorothioate in rats. Zhang R; Lu Z; Zhang X; Zhao H; Diasio RB; Liu T; Jiang Z; Agrawal S Clin Chem; 1995 Jun; 41(6 Pt 1):836-43. PubMed ID: 7768001 [TBL] [Abstract][Full Text] [Related]
53. Oligonucleotides conjugated with short chemically defined polyethylene glycol chains are efficient antisense agents. Shokrzadeh N; Winkler AM; Dirin M; Winkler J Bioorg Med Chem Lett; 2014 Dec; 24(24):5758-5761. PubMed ID: 25453815 [TBL] [Abstract][Full Text] [Related]
54. Synthesis and anti-HIV activity of thiocholesteryl-coupled phosphodiester antisense oligonucleotides incorporated into immunoliposomes. Zelphati O; Wagner E; Leserman L Antiviral Res; 1994 Sep; 25(1):13-25. PubMed ID: 7811058 [TBL] [Abstract][Full Text] [Related]
56. Synthesis of antisense oligonucleotides containing a photocleavable protecting group on a guanine base and their photoinduced duplex formation. Iwase R; Fukui U; Kobori A; Yamaoka T; Murakami A Nucleic Acids Symp Ser (Oxf); 2005; (49):151-2. PubMed ID: 17150678 [TBL] [Abstract][Full Text] [Related]
57. Minimally modified oligonucleotides - combination of end-capping and pyrimidine-protection. Peyman A; Uhlmann E Biol Chem Hoppe Seyler; 1996 Jan; 377(1):67-70. PubMed ID: 8929815 [TBL] [Abstract][Full Text] [Related]
58. Antimycobacterial activities of antisense oligodeoxynucleotide phosphorothioates in drug-resistant strains. Rapaport E; Levina A; Metelev V; Zamecnik PC Proc Natl Acad Sci U S A; 1996 Jan; 93(2):709-13. PubMed ID: 8570621 [TBL] [Abstract][Full Text] [Related]
59. Capped oligodeoxynucleotide phosphorothioates. Pharmacokinetics and stability in mice. Temsamani J; Tang JY; Agrawal S Ann N Y Acad Sci; 1992 Oct; 660():318-20. PubMed ID: 1340145 [No Abstract] [Full Text] [Related]
60. Oligodeoxynucleotides enhance lipopolysaccharide-stimulated synthesis of tumor necrosis factor: dependence on phosphorothioate modification and reversal by heparin. Hartmann G; Krug A; Waller-Fontaine K; Endres S Mol Med; 1996 Jul; 2(4):429-38. PubMed ID: 8827713 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]